Google Alert - thb-335

MTC ปลื้ม! หุ้นกู้เพื่อสังคมอายุ 4 ปี มูลค่า 335 ล้านดอลลาร์ คว้ารางวัลระดับภูมิภาค Thailand Capital ...

3 days ago

Dupixent bounces back in treating hives with FDA approval - BioWorld

18 days ago

Third Harmonic Bio Inc., of San Francisco, also is developing an oral...

Other news to note for April 15, 2025 - BioWorld

24 days ago

The sale of the company's assets, including THB-335, will be initiated pending...

Third Harmonic's shutdown, Coherus and Xoma drug sales connected - Bizwomen

24 days ago

... THB-335, to increase the chances of selling the asset. Otherwise, the...

Third Harmonic plots exit strategy, sale of urticaria drug - FirstWord Pharma

25 days ago

Third Harmonic Bio announced Monday that it plans to liquidate and dissolve...

Third Harmonic's song to end as biotech looks to liquidate, sell off urticaria drug

25 days ago

... THB335 by mid-year with the aim of securing the best price...

Third Harmonic Bio Announces Plan of Liquidation and Dissolution - Stock Titan

25 days ago

The company will complete Phase 2 readiness activities for THB335 by mid-year...

Third Harmonic Bio Announces Plan of Liquidation and Dissolution - BioSpace

25 days ago

... THB335 program. Per previous financial and operational guidance, the Company will...

Third Harmonic Bio股价周一上涨40%：发生了什么？ 港美股资讯 - 华盛通

25 days ago

这家处于临床阶段的生物制药公司指出，它计划在年中之前完成其THB 335计划的所有第二阶段准备工作，以便在潜在出售之前最大限度地提高该计划的价值。 Third ...

Bakan Kacır, “Tuşba Küçük Sanayi Sitesi 335 İşyeri Temel Atma Töreni'ne katıldı

29 days ago

... THB1,0870%0,12. TWD1,1443%0,06. UAH0,9224%0,07. UYU0,8923%0,12. GEL13,7611 ... Bakan Kacır, “Tuşba Küçük Sanayi...

써드하모닉바이오(THRD), 2024년 4분기 및 연간 재무 결과 발표 - 비욘드포스트

about 1 month ago

회사는 THB335의 1상 임상 데이터가 만성 자발성 두드러기(CSU)에서 2상 임상 시험으로의 진전을...

써드하모닉바이오(THRD), 2024년 연례 보고서 제출 - 비욘드포스트

about 1 month ago

회사는 THB335라는 차세대 구강용 KIT 억제제를 개발 중이며, 이 약물은 만성 자발성...